33631-04-8 Usage
Uses
Used in Pharmaceutical Synthesis:
3,4-Diamino-2-methoxypyridine is utilized as an intermediate in the synthesis of pharmaceuticals for its ability to be incorporated into the molecular structures of various drugs, enhancing their therapeutic properties.
Used in Dye and Pigment Manufacturing:
In the dye and pigment industry, 3,4-Diamino-2-methoxypyridine is employed as a building block for the creation of dyes and pigments, leveraging its chemical structure to produce a range of colorants with specific characteristics.
Used in Organic Compounds Synthesis:
3,4-Diamino-2-methoxypyridine serves as a key component in the synthesis of other organic compounds, contributing to the development of novel chemical entities with potential applications in different industries.
Used in Biological and Pharmacological Research:
3,4-Diamino-2-methoxypyridine is used as a subject of study in biological and pharmacological research due to its potential anti-tumor and anti-inflammatory properties, which may lead to the discovery of new therapeutic agents.
Used in Material Science and Coatings Development:
In the field of material science, 3,4-Diamino-2-methoxypyridine is explored for its potential use in developing new materials and coatings, capitalizing on its unique chemical properties to create innovative products with enhanced performance.
Check Digit Verification of cas no
The CAS Registry Mumber 33631-04-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,6,3 and 1 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 33631-04:
(7*3)+(6*3)+(5*6)+(4*3)+(3*1)+(2*0)+(1*4)=88
88 % 10 = 8
So 33631-04-8 is a valid CAS Registry Number.
33631-04-8Relevant academic research and scientific papers
Polycyclic compound for inhibiting RNA helicase DHX33
-
Paragraph 0230-0233, (2021/04/17)
The invention relates to a polycyclic compound for inhibiting RNA helicase DHX33. In particular, the invention relates to a compound shown as a formula I or a pharmaceutically acceptable form thereof, a pharmaceutical composition containing the compound, a preparation method of the compound, and medical application of the compound to prevention and/or treatment of DHX33 related diseases.
Method for preparing 3-aminopyridines from 3-nitropyridines
-
, (2008/06/13)
The present invention relates to a method for preparing 3-aminopyridines from 3-nitropyridines, in which the nitropyridines are reduced electrochemically in acidic solution.
Diaminopyridine compounds and methods of use
-
, (2008/06/13)
The present invention relates to compositions and method for inhibiting nonenzymatic cross-linking (protein aging) which contain diaminopyridines and derivates thereof. Accordingly, a composition is disclosed which comprises an agent capable of inhibiting the formation of advanced glycosylation endproducts of target proteins by reacting with the carbonyl moiety of the early glycosylation product of such target proteins formed by their initial glycosylation. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated.
